EMEA-001438-PIP01-13-M01
Key facts
Invented name |
Praxbind
|
Active substance |
idarucizumab
|
Therapeutic area |
Other
|
Decision number |
P/0151/2019
|
PIP number |
EMEA-001438-PIP01-13-M01
|
Pharmaceutical form(s) |
Solution for injection/infusion
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001438-PIP01-13-M01
|
Compliance opinion date |
24/07/2020
|
Compliance outcome |
positive
|